Literature DB >> 20839017

Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors.

Erica Cristina Moreno Nascimento1, João B L Martins.   

Abstract

Hartree-Fock and density functional methods were used to analyze electronic and structural properties of known drugs to evaluate the influence of these data on acetylcholinesterase inhibition. The energies of the frontier orbitals and the distances between the more acidic hydrogen species were investigated to determine their contributions to the activity of a group of acetylcholinesterase inhibitors. Electrostatic potential maps indicated suitable sites for drugs-enzyme interactions. In this study, the structural, electronic and spatial properties of nine drugs with known inhibitory effects on acetylcholinesterase were examined. The data were obtained based on calculations at the B3LYP/6-31 + G(d,p) level. Multivariate principal components analysis was applied to 18 parameters to determine the pharmacophoric profile of acetylcholinesterase inhibitors. Desirable features for acetylcholinesterase inhibitor molecules include aromatic systems or groups that simulate the surface electrostatic potential of aromatic systems and the presence of a sufficient number of hydrogen acceptors and few hydrogen donors. PCA showed that electronic properties, including the HOMO-1 orbital energy, logP and aromatic system quantity, as well as structural data, such as volume, size and H-H distance, are the most significant properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20839017     DOI: 10.1007/s00894-010-0838-x

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  26 in total

1.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.

Authors:  G Kryger; I Silman; J L Sussman
Journal:  Structure       Date:  1999-03-15       Impact factor: 5.006

Review 2.  Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.

Authors:  J Kaur; M Q Zhang
Journal:  Curr Med Chem       Date:  2000-03       Impact factor: 4.530

Review 3.  Synthesis of tacrine analogues and their structure-activity relationships.

Authors:  G R Proctor; A L Harvey
Journal:  Curr Med Chem       Date:  2000-03       Impact factor: 4.530

4.  Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.

Authors:  Edwin H Rydberg; Boris Brumshtein; Harry M Greenblatt; Dawn M Wong; David Shaya; Larry D Williams; Paul R Carlier; Yuan-Ping Pang; Israel Silman; Joel L Sussman
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

5.  Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine.

Authors:  P Bar-On; C B Millard; M Harel; H Dvir; A Enz; J L Sussman; I Silman
Journal:  Biochemistry       Date:  2002-03-19       Impact factor: 3.162

6.  Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.

Authors:  Maria Laura Bolognesi; Manuela Bartolini; Andrea Cavalli; Vincenza Andrisano; Michela Rosini; Anna Minarini; Carlo Melchiorre
Journal:  J Med Chem       Date:  2004-11-18       Impact factor: 7.446

7.  Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution.

Authors:  H M Greenblatt; G Kryger; T Lewis; I Silman; J L Sussman
Journal:  FEBS Lett       Date:  1999-12-17       Impact factor: 4.124

8.  Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.

Authors:  Miho Yamada Mizutani; Akiko Itai
Journal:  J Med Chem       Date:  2004-09-23       Impact factor: 7.446

9.  Synthesis and structure-activity relationships of open D-Ring galanthamine analogues.

Authors:  Denyse Herlem; Marie Thérèse Martin; Claude Thal; Catherine Guillou
Journal:  Bioorg Med Chem Lett       Date:  2003-07-21       Impact factor: 2.823

10.  Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM/MM study.

Authors:  Yingkai Zhang; Jeremy Kua; J Andrew McCammon
Journal:  J Am Chem Soc       Date:  2002-09-04       Impact factor: 15.419

View more
  5 in total

1.  Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction.

Authors:  Alessandra S Kiametis; Mônica A Silva; Luiz A S Romeiro; João B L Martins; Ricardo Gargano
Journal:  J Mol Model       Date:  2017-02-09       Impact factor: 1.810

2.  Mapping of the interaction sites of galanthamine: a quantitative analysis through pairwise potentials and quantum chemistry.

Authors:  Nicolas Galland; Soleymane Kone; Jean-Yves Le Questel
Journal:  J Comput Aided Mol Des       Date:  2012-09-13       Impact factor: 3.686

3.  In silico study of tacrine and acetylcholine binding profile with human acetylcholinesterase: docking and electronic structure.

Authors:  Letícia A Nascimento; Érica C M Nascimento; João B L Martins
Journal:  J Mol Model       Date:  2022-08-10       Impact factor: 2.172

4.  Similarity search combined with docking and molecular dynamics for novel hAChE inhibitor scaffolds.

Authors:  Nadia Melo Borges; Geraldo Rodrigues Sartori; Jean F R Ribeiro; Josmar R Rocha; João B L Martins; Carlos A Montanari; Ricardo Gargano
Journal:  J Mol Model       Date:  2018-01-13       Impact factor: 1.810

5.  Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.

Authors:  Premkumar Jayaraman; Kishore R Sakharkar; ChuSing Lim; Mohammad Imran Siddiqi; Sarinder K Dhillon; Meena K Sakharkar
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.